小児用灌流システム市場の2030年までの予測：製品別、用途別、エンドユーザー別、地域別の世界分析

世界の小児用灌流システム市場は、2023年に3億4,696万米ドルとなり、2030年までに6億2,616万米ドルに達すると予測され、予測期間中のCAGRは8.8%で成長する見込みです。

小児用灌流システムは、心臓手術中に心肺バイパスを必要とする乳幼児や小児のために特別に作られた医療用セットアップです。小児特有の生理学に合わせたこれらのシステムには、小型の酸素供給装置、ポンプ、チューブ、モニタリング装置などが含まれます。これらのシステムは、手技中の酸素補給、体温調節、血液循環などの重要な機能を維持し、低年齢の患者特有のニーズを考慮しながら、小児の心臓手術を安全かつ効果的にサポートします。

米国心臓協会のファクトシート2022によると、先天性心疾患は米国で毎年約4万人の乳児に影響を及ぼすと予想されています。

先天性心疾患の発生率の増加

世界的に乳幼児や小児の先天性心疾患の有病率が増加していることは、小児用灌流システム市場の重要な促進要因となっています。意識の高まりと診断能力の向上により、より多くの症例が早期に発見され、高度な心臓手術が必要となっています。小児用灌流システムは、これらの手術において重要な役割を果たし、小児患者の小さな解剖学的構造と独特の生理学的要件に合わせた特別なサポートを提供します。先天性心疾患の増加により心臓手術の需要が高まるにつれ、効果的な灌流システムの必要性も高まっています。

機器と処置の高コスト

小児用灌流システムおよび関連手技に関連するコストが高いことが、市場の大きな抑制要因となっています。小児患者用に調整された機器の特殊性が、厳しい安全基準や高度な技術と相まって、コスト上昇の一因となっています。さらに、これらのシステムの保守やアップグレードにかかる費用や、高度に熟練した人材の必要性が、全体的な支出をさらにエスカレートさせています。このような高コストが、特定のヘルスケア施設や地域でのアクセスを制限し、小児心臓手術におけるこれらのシステムの重要な必要性にもかかわらず、普及を妨げています。

カスタマイズされたソリューションへの需要の高まり

小児患者には多様な解剖学的・生理学的ニーズがあり、こうした多様性に対応するためのオーダーメイドのシステムや技術が重視されるようになっています。調節可能なポンプ、小型の酸素供給装置、特殊なモニタリング装置など、適応可能で患者に特化したソリューションに重点を置く企業は、この動向を活用することができます。特定の患者の要求に応えるカスタマイズされたオプションを提供することは、患者の転帰を向上させるだけでなく、競争力を確立し、小児用灌流システムの革新と市場拡大を促進します。

急速な技術変化

急速な技術革新は、既存のシステムを陳腐化させる危険性があるため、市場に脅威をもたらします。絶え間ない進歩は機器のライフサイクルの短縮につながり、現行システムの時代遅れを早める可能性があります。そのため、頻繁なアップグレードや新しい技術への投資が必要となり、ヘルスケア施設のコストが増加します。さらに、更新されたシステムに関するスタッフのトレーニングの必要性や、進化する標準との互換性の確保は、ロジスティクス上の課題となるかもしれません。このような迅速な技術進化のペースは、現在のソリューションへの投資を抑制し、市場の安定性に影響を与える可能性があります。

COVID-19の影響：

COVID-19の流行は、これらのシステムが重要な役割を果たす小児心臓手術を含む待機的手術に混乱を引き起こし、市場に影響を及ぼしています。病院の収容能力の低下、資源の再配分、安全対策により、緊急手術以外の手術が延期されました。このため小児用灌流システムの需要は一時的に減少し、市場の成長に影響を与えました。しかし、多くの小児心臓手術は緊急性が高いため、こうした課題にもかかわらず一定の需要が維持されています。

予測期間中、小児用酸素供給装置分野が最大になる見込み

小児用酸素供給装置分野は、小児心臓手術の際に不可欠な酸素供給サポートを提供するという極めて重要な役割を担っているため、市場の大半を占めると予測されています。このような手術では、少ない血液量と小児特有の生理学に合わせた正確な酸素供給が必要となるため、特殊な酸素供給装置が極めて重要です。さらに、先天性心疾患の発生率の上昇と小児心臓手術の需要が、効率的で適応性の高い酸素供給装置の必要性を高めており、このセグメントを小児用灌流システムの要として位置づけ、市場の優位性を確保する原動力となっています。

予測期間中、製薬企業・バイオテクノロジー企業が最も高いCAGRを示すと予測されています。

製薬・バイオ企業セグメントは、小児用灌流システムに焦点を当てた研究開発の増加により、最も高い成長率が見込まれています。これらの企業は、革新的な技術、薬剤開発、小児心臓手術に対応する特殊機器に幅広く投資しています。小児患者に合わせたソリューションを重視する傾向が強まる中、製薬企業やバイオテクノロジー企業は先進的な灌流システムの開発でリードしており、予測期間中にこの分野で高い成長率が予測される原動力となっています。

最大シェアの地域：

北米は、高度なヘルスケアインフラ、充実した研究開発投資、先天性心疾患の高い有病率により、最大の市場シェアを占めると見られています。また、同地域には小児心臓センターが整備されており、研究機関と製薬会社の協力体制も整っています。好意的な償還政策と主要市場プレイヤーの存在が、洗練された小児用灌流システムの採用と導入における北米の優位性をさらに高め、大きな市場シェアを確保しています。

CAGRが最も高い地域：

アジア太平洋は、ヘルスケア支出の増加、小児心臓ケアに対する意識の高まり、小児人口の増加により、大きな成長を遂げることが予想されます。新興国はヘルスケアインフラの改善と技術導入を目の当たりにしており、高度な灌流システムの需要を促進しています。さらに、世界企業との提携、政府のイニシアティブ、小児心臓手術センターの拡大が、この地域の高度な小児用灌流システムの導入と統合における大幅な成長の可能性に寄与しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 用途分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の小児用灌流システム市場：製品別

• 監視システム
• 小児動脈フィルター
• 小児用血液ポンプ
• 小児用カニューレ・カテーテル
• 小児用人工肺
• その他の製品

第6章 世界の小児用灌流システム市場：用途別

• 心臓手術
• 臓器移植
• 体外生命維持装置（ECLS/ECMO）
• その他の用途

第7章 世界の小児用灌流システム市場：エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター
• 製薬会社・バイオテクノロジー企業
• その他のエンドユーザー

第8章 世界の小児用灌流システム市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東・アフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Baxter International Inc.
• Braile Biomedica
• Edwards Lifesciences Corporation
• Getinge Group
• Hemovent GmbH
• LeMaitre Vascular, Inc.
• LivaNova
• Medtronic
• MicroPort Scientific Corporation
• Nipro Medical Corporation
• Perfusion.com, Inc.
• Sorin Group
• Spectrum Medical
• Stryker Corporation
• Terumo Cardiovascular
• Xenios AG

List of Tables

• Table 1 Global Pediatric Perfusion Systems Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Pediatric Perfusion Systems Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2021-2030) ($MN)
• Table 4 Global Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2021-2030) ($MN)
• Table 5 Global Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2021-2030) ($MN)
• Table 6 Global Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2021-2030) ($MN)
• Table 7 Global Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2021-2030) ($MN)
• Table 8 Global Pediatric Perfusion Systems Market Outlook, By Other Products (2021-2030) ($MN)
• Table 9 Global Pediatric Perfusion Systems Market Outlook, By Application (2021-2030) ($MN)
• Table 10 Global Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2021-2030) ($MN)
• Table 11 Global Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 12 Global Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2021-2030) ($MN)
• Table 13 Global Pediatric Perfusion Systems Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 14 Global Pediatric Perfusion Systems Market Outlook, By End User (2021-2030) ($MN)
• Table 15 Global Pediatric Perfusion Systems Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 16 Global Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 17 Global Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 18 Global Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 19 Global Pediatric Perfusion Systems Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 20 North America Pediatric Perfusion Systems Market Outlook, By Country (2021-2030) ($MN)
• Table 21 North America Pediatric Perfusion Systems Market Outlook, By Product (2021-2030) ($MN)
• Table 22 North America Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2021-2030) ($MN)
• Table 23 North America Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2021-2030) ($MN)
• Table 24 North America Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2021-2030) ($MN)
• Table 25 North America Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2021-2030) ($MN)
• Table 26 North America Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2021-2030) ($MN)
• Table 27 North America Pediatric Perfusion Systems Market Outlook, By Other Products (2021-2030) ($MN)
• Table 28 North America Pediatric Perfusion Systems Market Outlook, By Application (2021-2030) ($MN)
• Table 29 North America Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2021-2030) ($MN)
• Table 30 North America Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 31 North America Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2021-2030) ($MN)
• Table 32 North America Pediatric Perfusion Systems Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 33 North America Pediatric Perfusion Systems Market Outlook, By End User (2021-2030) ($MN)
• Table 34 North America Pediatric Perfusion Systems Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 35 North America Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 36 North America Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 37 North America Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 38 North America Pediatric Perfusion Systems Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 39 Europe Pediatric Perfusion Systems Market Outlook, By Country (2021-2030) ($MN)
• Table 40 Europe Pediatric Perfusion Systems Market Outlook, By Product (2021-2030) ($MN)
• Table 41 Europe Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2021-2030) ($MN)
• Table 42 Europe Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2021-2030) ($MN)
• Table 43 Europe Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2021-2030) ($MN)
• Table 44 Europe Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2021-2030) ($MN)
• Table 45 Europe Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2021-2030) ($MN)
• Table 46 Europe Pediatric Perfusion Systems Market Outlook, By Other Products (2021-2030) ($MN)
• Table 47 Europe Pediatric Perfusion Systems Market Outlook, By Application (2021-2030) ($MN)
• Table 48 Europe Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2021-2030) ($MN)
• Table 49 Europe Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 50 Europe Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2021-2030) ($MN)
• Table 51 Europe Pediatric Perfusion Systems Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 52 Europe Pediatric Perfusion Systems Market Outlook, By End User (2021-2030) ($MN)
• Table 53 Europe Pediatric Perfusion Systems Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 54 Europe Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 55 Europe Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 56 Europe Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 57 Europe Pediatric Perfusion Systems Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 58 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Country (2021-2030) ($MN)
• Table 59 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Product (2021-2030) ($MN)
• Table 60 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2021-2030) ($MN)
• Table 61 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2021-2030) ($MN)
• Table 62 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2021-2030) ($MN)
• Table 63 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2021-2030) ($MN)
• Table 64 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2021-2030) ($MN)
• Table 65 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Other Products (2021-2030) ($MN)
• Table 66 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Application (2021-2030) ($MN)
• Table 67 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2021-2030) ($MN)
• Table 68 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 69 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2021-2030) ($MN)
• Table 70 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 71 Asia Pacific Pediatric Perfusion Systems Market Outlook, By End User (2021-2030) ($MN)
• Table 72 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 73 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 74 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 75 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 76 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 77 South America Pediatric Perfusion Systems Market Outlook, By Country (2021-2030) ($MN)
• Table 78 South America Pediatric Perfusion Systems Market Outlook, By Product (2021-2030) ($MN)
• Table 79 South America Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2021-2030) ($MN)
• Table 80 South America Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2021-2030) ($MN)
• Table 81 South America Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2021-2030) ($MN)
• Table 82 South America Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2021-2030) ($MN)
• Table 83 South America Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2021-2030) ($MN)
• Table 84 South America Pediatric Perfusion Systems Market Outlook, By Other Products (2021-2030) ($MN)
• Table 85 South America Pediatric Perfusion Systems Market Outlook, By Application (2021-2030) ($MN)
• Table 86 South America Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2021-2030) ($MN)
• Table 87 South America Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 88 South America Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2021-2030) ($MN)
• Table 89 South America Pediatric Perfusion Systems Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 90 South America Pediatric Perfusion Systems Market Outlook, By End User (2021-2030) ($MN)
• Table 91 South America Pediatric Perfusion Systems Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 92 South America Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 93 South America Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 94 South America Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 95 South America Pediatric Perfusion Systems Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 96 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Country (2021-2030) ($MN)
• Table 97 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Product (2021-2030) ($MN)
• Table 98 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2021-2030) ($MN)
• Table 99 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2021-2030) ($MN)
• Table 100 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2021-2030) ($MN)
• Table 101 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2021-2030) ($MN)
• Table 102 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2021-2030) ($MN)
• Table 103 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Other Products (2021-2030) ($MN)
• Table 104 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Application (2021-2030) ($MN)
• Table 105 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2021-2030) ($MN)
• Table 106 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2021-2030) ($MN)
• Table 107 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2021-2030) ($MN)
• Table 108 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 109 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By End User (2021-2030) ($MN)
• Table 110 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 111 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 112 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 113 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
• Table 114 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Pediatric Perfusion Systems Market is accounted for $346.96 million in 2023 and is expected to reach $626.16 million by 2030 growing at a CAGR of 8.8% during the forecast period. Pediatric perfusion systems are specialised medical setups crafted specifically for infants and children requiring cardiopulmonary bypass during cardiac surgeries. Tailored to their unique physiologies, these systems include smaller oxygenators, pumps, tubing and monitoring devices. They maintain vital functions like oxygenation, temperature control and blood circulation during procedures, ensuring safe and effective support for pediatric cardiac surgery while considering the unique needs of younger patients.

According to American Heart Association, Inc.'s fact sheet 2022, congenital heart defects are expected to affect around 40,000 infants in the U.S. each year.

Market Dynamics:

Driver:

Rising incidence of congenital heart defects

The increasing prevalence of congenital heart defects among infants and children globally serves as a significant driver in the pediatric Perfusion systems market. With rising awareness and improved diagnostic capabilities, more cases are being identified early, necessitating advanced cardiac surgeries. Pediatric perfusion systems play a crucial role in these surgeries, providing specialised support tailored to the smaller anatomies and unique physiological requirements of pediatric patients. As the demand for corrective cardiac procedures rises due to the growing incidence of congenital heart defects, the need for effective perfusion systems amplifies accordingly.

Restraint:

High cost of equipment and procedures

The high cost associated with pediatric perfusion systems and related procedures poses a significant restraint on the market. The specialised nature of equipment tailored for pediatric patients, coupled with stringent safety standards and advanced technologies, contributes to elevated costs. Additionally, the expenses incurred in maintaining and upgrading these systems, along with the need for highly skilled personnel, further escalate the overall expenditure. This high cost limits accessibility for certain healthcare facilities or regions, hindering widespread adoption despite the critical need for these systems in pediatric cardiac surgeries.

Opportunity:

Growing demand for customized solutions

Pediatric patients exhibit diverse anatomies and physiological needs, and there's a growing emphasis on tailored systems and technologies to address these variations. Companies focusing on adaptable, patient-specific solutions, such as adjustable pumps, smaller oxygenators, and specialised monitoring devices, can capitalise on this trend. Offering customised options that cater to specific patient requirements not only enhances patient outcomes but also establishes a competitive edge, fostering innovation and market expansion in pediatric perfusion systems.

Threat:

Rapid technological changes

Rapid technological changes pose a threat to the market due to the risk of rendering existing systems obsolete. Continuous advancements may lead to shorter lifecycles for equipment, potentially making current systems outdated faster. This necessitates frequent upgrades or investments in newer technologies, increasing costs for healthcare facilities. Additionally, the need for training staff on updated systems and ensuring compatibility with evolving standards can create logistical challenges. This swift pace of technological evolution might deter investments in current solutions, impacting market stability.

Covid-19 Impact:

The COVID-19 pandemic has influenced the market by causing disruptions in elective surgeries, including pediatric cardiac procedures, where these systems are crucial. Reduced hospital capacities, redirected resources, and safety measures resulted in deferred non-emergency surgeries. This decreased demand for pediatric perfusion systems temporarily, affecting market growth. However, the urgent nature of many pediatric cardiac surgeries has sustained some demand despite these challenges.

The pediatric oxygenators segment is expected to be the largest during the forecast period

The pediatric oxygenators segment is anticipated to dominate due to its pivotal role in providing essential oxygenation support during pediatric cardiac surgeries. As these procedures require precise and tailored oxygenation for smaller blood volumes and unique pediatric physiology, specialised oxygenators are crucial. Additionally, the rising incidence of congenital heart defects and the demand for pediatric cardiac interventions drive the need for efficient and adaptable oxygenators, positioning this segment as a cornerstone in pediatric perfusion systems and thus driving its expected market dominance.

The pharmaceutical and biotech companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical and biotech companies segment anticipates the highest growth rate owing to increased research and development focused on pediatric perfusion systems. These companies invest extensively in innovative technologies, drug development and specialised equipment catering to pediatric cardiac surgeries. With a growing emphasis on tailored solutions for pediatric patients, pharmaceutical and biotech firms are leading in developing advanced perfusion systems, thus driving the projected high growth rate in this segment during the forecast period.

Region with largest share:

North America is positioned to hold the largest market share due to advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of congenital heart defects. Additionally, the region boasts well-established pediatric cardiac centers and collaborations between research institutes and pharmaceutical companies. Favorable reimbursement policies and the presence of key market players further contribute to North America's dominance in adopting and implementing sophisticated pediatric perfusion systems, securing a significant market share.

Region with highest CAGR:

The Asia-Pacific region is set to experience significant growth owing to the rising healthcare expenditure, increasing awareness about pediatric cardiac care and a growing pediatric population. Emerging economies are witnessing improvements in healthcare infrastructure and technology adoption, fostering the demand for advanced perfusion systems. Moreover, collaborations with global players, government initiatives and expanding pediatric cardiac surgery centres contribute to the region's substantial growth potential in adopting and integrating sophisticated pediatric perfusion systems.

Key players in the market

Some of the key players in Pediatric Perfusion Systems Market include Baxter International Inc., Braile Biomedica, Edwards Lifesciences Corporation, Getinge Group, Hemovent GmbH, LeMaitre Vascular, Inc., LivaNova, Medtronic, MicroPort Scientific Corporation, Nipro Medical Corporation, Perfusion.com, Inc., Sorin Group, Spectrum Medical, Stryker Corporation, Terumo Cardiovascular and Xenios AG.

Key Developments:

In December 2023, Vascular Perfusion Solutions (VPS), Inc., is a San Antonio based medical device startup company focused on developing novel prolonged organ preservation technologies prior to transplantation, has received a $25,000 grant from the Southwest-Midwest National Pediatric Device Innovation Consortium (SWPDC).

In March 2023, LivaNova PLC, a market-leading medical technology and innovation company, announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lung Machine (HLM). With FDA clearance, LivaNova initiates the commercial launch of Essenz in the U.S. The Company also recently received approval for the Essenz HLM from Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

Products Covered:

• Monitoring Systems
• Pediatric Arterial Filters
• Pediatric Blood Pumps
• Pediatric Cannulas and Catheters
• Pediatric Oxygenators
• Other Products

Applications Covered:

• Cardiac Surgeries
• Organ Transplantation
• Extracorporeal Life Support (ECLS/ECMO)
• Other Applications

End Users Covered:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Pharmaceutical and Biotech Companies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pediatric Perfusion Systems Market, By Product

• 5.1 Introduction
• 5.2 Monitoring Systems
• 5.3 Pediatric Arterial Filters
• 5.4 Pediatric Blood Pumps
• 5.5 Pediatric Cannulas and Catheters
• 5.6 Pediatric Oxygenators
• 5.7 Other Products

6 Global Pediatric Perfusion Systems Market, By Application

• 6.1 Introduction
• 6.2 Cardiac Surgeries
• 6.3 Organ Transplantation
• 6.4 Extracorporeal Life Support (ECLS/ECMO)
• 6.5 Other Applications

7 Global Pediatric Perfusion Systems Market, By End User

• 7.1 Introduction
• 7.2 Hospitals
• 7.3 Specialty Clinics
• 7.4 Ambulatory Surgical Centers
• 7.5 Pharmaceutical and Biotech Companies
• 7.6 Other End Users

8 Global Pediatric Perfusion Systems Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Baxter International Inc.
• 10.2 Braile Biomedica
• 10.3 Edwards Lifesciences Corporation
• 10.4 Getinge Group
• 10.5 Hemovent GmbH
• 10.6 LeMaitre Vascular, Inc.
• 10.7 LivaNova
• 10.8 Medtronic
• 10.9 MicroPort Scientific Corporation
• 10.10 Nipro Medical Corporation
• 10.11 Perfusion.com, Inc.
• 10.12 Sorin Group
• 10.13 Spectrum Medical
• 10.14 Stryker Corporation
• 10.15 Terumo Cardiovascular
• 10.16 Xenios AG